Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - IASO BioMed, Inc. | iaso8kheinmossadams112217fin.htm |
EXHIBIT 16.1
November 22, 2017
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read IASO BioMed’s statements included under Item 4.01 of its Form 8-K filed on November 22, 2017 and we agree with such statements concerning our firm.
/s/ Hein & Associates LLP
Hein & Associates LLP